AMBEA AB (PUBL) HAS COMPLETED THE SHARE REPURCHASE PROGRAM IN CONNECTION WITH THE RECOMMENDED PUBLIC OFFER TO THE SHAREHOLDERS OF HUMANA AB

The Board of Directors of Ambea AB (publ) (“Ambea”) announces that the share repurchase program announced on 29 June 2026 has now been completed.

The objective of the share repurchase program was to enable the shares to be used for capital structure purposes or acquisitions, primarily to ensure that Ambea holds sufficient own shares (together with new shares that may be issued) to be used as consideration in the recommended public offer to the shareholders of Humana AB (“Humana”), which was announced on 29 June 2026 (the “Offer”).

Through the completed repurchases, Ambea has now acquired the number of own shares that the company intended to acquire under the share repurchase program.

The share repurchase program was carried out pursuant to the authorisation granted by the Annual General Meeting 2026 and in accordance with Nasdaq Stockholm’s Rulebook for Issuers.

Further information regarding the Offer to the shareholders of Humana is available at www.care-for-tomorrow.com/en.

The total number of shares in Ambea amounts to 80,384,424. At the time of this press release, Ambea holds 5,560,658 own shares.

The information was submitted for publication, through the agency of the contact person below, on September 8, 2026, at 10:30 CEST.

Administrative questions

For administrative questions regarding the Offer, please contact your bank or nominee where your shares are registered.

Questions regarding the repurchase program

Benno Eliasson, CFO

E-mail: ir@ambea.se

Other questions regarding the Offer:

Fogel & Partners, Sandra Uitto, for further distribution as relevant

Telephone: +46 725 56 68 88

Email: ambea@fogelpartners.se

Ambea is the leading competence-based care company in the Nordics. Ambea has over 41,000 employees who are creating a good life for more than 18,000 care receivers in our more than 1,000 units across the Nordics. We aim to be the quality leader in all that we do and our vision is to make the world a better place, one person at a time. Ambeas head office is located in Solna, Sweden. Ambea is listed on Nasdaq Stockholm.